🧠

Algau - Intelligence Assistant

Medicare prescription drug economics under varying rebate assumptions. Powered by ALGAURIZIN intelligence.

💰 Brand Rebate Impact

Analyze the effect of increasing brand drug rebates on total program spending

📊 Manufacturer Analysis

Identify companies with the largest difference between gross and net spend

💊 Claim Economics

Examine per-claim spending patterns across different manufacturers

📉 Scenario Modeling

Project the impact of higher generic drug rebates on program costs

📊 Dashboard Parameters

Part D Spending Overview

Gross vs net analysis based on selected rebate assumptions

📈 Gross vs Net Spending by Manufacturer

🏭 Top Manufacturers Analysis

CMS Disclosure Note: The Part D spending metrics do not reflect any manufacturers' rebates or other price concessions as CMS is prohibited from publicly disclosing such information. The rebate assumptions used in this analysis are illustrative estimates based on industry benchmarks.